Cited by 46

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder

Frankel, Lisa B., Di Malta, Chiara, Wen, Jiayu, Eskelinen, Eeva-Liisa, Ballabio, Andrea, Lund, Anders H.·2014·Nature Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms6840

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 50

  1. Gualeni, B. et al. Alteration of proteoglycan sulfation affects bone growth and remodeling. Bone 54, 83–91 (2013). · DOI
  2. Dawson, P. A. Role of sulphate in development. Reproduction 146, R81–R89 (2013). · DOI
  3. Lum, D. H., Tan, J., Rosen, S. D. & Werb, Z. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol. Cell. Biol. 27, 678–688 (2006). · DOI
  4. Settembre, C. et al. Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. Proc. Natl Acad. Sci. USA 104, 4506–4511 (2007). · DOI
  5. Settembre, C. et al. Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes Dev. 22, 2645–2650 (2008). · DOI
  6. Sardiello, M., Annunziata, I., Roma, G. & Ballabio, A. Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum. Mol. Genet. 14, 3203–3217 (2005). · DOI
  7. Diez-Roux, G. & Ballabio, A. Sulfatases and human disease. Annu. Rev. Genomics Hum. Genet. 6, 355–379 (2005). · DOI
  8. Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell 147, 728–741 (2011). · DOI
  9. Settembre, C. et al. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 17, 119–129 (2007). · DOI
  10. Ballabio, A. & Gieselmann, V. Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta 1793, 684–696 (2009). · DOI · Paper page
  11. Lieberman, A. P. et al. Autophagy in lysosomal storage disorders. Autophagy 8, 719–730 (2012). · DOI · Paper page
  12. Cosma, M. P. et al. The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell 113, 445–456 (2003). · DOI
  13. Dierks, T. et al. Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell 113, 435–444 (2003). · DOI
  14. Zito, E. et al. Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum. EMBO J. 26, 2443–2453 (2007). · DOI
  15. Cech, T. R. & Steitz, J. A. The noncoding RNA revolution—trashing old rules to forge new ones. Cell 157, 77–94 (2014). · DOI · Paper page
  16. Ebert, M. S. & Sharp, P. A. Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515–524 (2012). · DOI · Paper page
  17. Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875–886 (2008). · DOI
  18. Liu, N. et al. Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy. J. Clin. Invest. 121, 3258–3268 (2011). · DOI
  19. Liu, N. et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242–3254 (2008). · DOI
  20. Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172–1187 (2012). · DOI · Paper page
  21. Frankel, L. B. et al. microRNA-101 is a potent inhibitor of autophagy. EMBO J. 30, 4628–4641 (2011). · DOI · Paper page
  22. Chen, X., Chen, S., Hang, W., Huang, H. & Ma, H. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer. Biomed. Pharmacother. 68, 589–595 (2014). · DOI
  23. Huang, Z. et al. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res. 71, 2582–2589 (2011). · DOI
  24. Huang, X. et al. miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res. 73, 6972–6986 (2013). · DOI
  25. Xiao, Z. et al. Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma. Eur. J. Pharmacol. 728, 141–150 (2014). · DOI
  26. Pankiv, S. et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131–24145 (2007). · DOI · Paper page
  27. Farkas, T., Høyer-Hansen, M. & Jäättelä, M. Identification of novel autophagy regulators by a luciferase-based assay for the kinetics of autophagic flux. Autophagy 5, 1018–1025 (2009). · DOI
  28. Gregersen, L. H. et al. MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells. BMC Cancer 12, 232 (2012). · DOI
  29. Christoffersen, N. R. et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17, 236–245 (2010). · DOI · Paper page
  30. Steckel, F., Hasilik, A. & von Figura, K. Multiple sulfatase deficiency: degradation of arylsulfatase A and B after endocytosis in fibroblasts. Eur. J. Biochem. 151, 147–152 (1985). · DOI
  31. Buono, M. & Cosma, M. P. Sulfatase activities towards the regulation of cell metabolism and signaling in mammals. Cell. Mol. Life Sci. 67, 769–780 (2010). · DOI
  32. Cosma, M. P. et al. Molecular and functional analysis ofSUMF1 mutations in multiple sulfatase deficiency. Hum. Mutat. 23, 576–581 (2004). · DOI
  33. Rohrbach, M. & Clarke, J. T. R. Treatment of lysosomal storage disorders: progress with enzyme replacement therapy. Drugs 67, 2697–2716 (2007). · DOI
  34. Zhang, Y. et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J. Surg. 33, 698–709 (2009). · DOI
  35. Nurul-Syakima, A. M. et al. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int. J. Mol. Med. 28, 327–336 (2011).
  36. Cordaux, R. & Batzer, M. A. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 10, 691–703 (2009). · DOI
  37. Platt, F. M., Boland, B. & van der Spoel, A. C. The cell biology of disease: Lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J. Cell Biol. 199, 723–734 (2012). · DOI · Paper page
  38. Ozsait, B. et al. Niemann-Pick type C fibroblasts have a distinct microRNA profile related to lipid metabolism and certain cellular components. Biochem. Biophys. Res. Commun. 403, 316–321 (2010). · DOI
  39. Dierks, T. et al. Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann–Pick C1 disease—Lysosomal storage disorders caused by defects of non-lysosomal proteins. Biochim. Biophys. Acta 1793, 710–725 (2009). · DOI
  40. Schlotawa, L. et al. Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency. Eur. J. Hum. Genet. 21, 1020–1023 (2013). · DOI
  41. Boustany, R.-M. N. Lysosomal storage diseases-the horizon expands. Nat. Rev. Neurol. 9, 583–598 (2013). · DOI
  42. Stenvang, J., Silahtaroglu, A. N., Lindow, M., Elmen, J. & Kauppinen, S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin. Cancer Biol. 18, 89–102 (2008). · DOI
  43. Obad, S. et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 43, 371–378 (2011). · DOI
  44. Janssen, H. L. A. et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685–1694 (2013). · DOI
  45. Høyer-Hansen, M. et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol. Cell 25, 193–205 (2007). · DOI · Paper page
  46. Yiş, U. et al. Multiple sulfatase deficiency in a Turkish family resulting from a novel mutation. Brain Dev. 30, 374–377 (2008). · DOI
  47. Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M. & Pascual-Montano, A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 8, R3 (2007). · DOI
  48. Nogales-Cadenas, R. et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 37, W317–W322 (2009). · DOI
  49. Tabas-Madrid, D., Nogales-Cadenas, R. & Pascual-Montano, A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 40, W478–W483 (2012). · DOI
  50. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91–105 (2007). · DOI · Paper page

Cited by

Sorted by citations

See all 46

Metadata

Authors
Frankel, L. B., Di Malta, C., Wen, J., Eskelinen, E.-L., Ballabio, A., & Lund, A. H.
Venue
Nature Communications
Published
2014-12-19
Volume
5
Issue
1
ISSN
2041-1723
Cited by
46
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review